Carmen Montes Gaisán

Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma

Gala Vega, Daniel Morillo, Christine Riedhammer, Febe Smits et autres

es, de, nl, us (code pays fourni par la source)

Sustained remission following limited duration of bispecific antibody therapy in patients with relapsed/refractory multiple myeloma

Gala Vega, Daniel Morillo, Christine Riedhammer, Aishee Bag et autres

es, de, us, fr (code pays fourni par la source)

Sustained Remission After Limited-Duration of Bispecific Antibody Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Gala Vega, Daniel Morillo, Christine Riedhammer, Aishee Bag et autres

Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients

Ingrid Alexandre, Juan José Domínguez-García, Elena Alejo, Ana Pilar González et autres

es (code pays fourni par la source)

Variables Associated with the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients

Ana Pena, Joel Dominguez-Garcia, Ester Alonso, Alexandre González-Rodríguez et autres

es (code pays fourni par la source)

About a case. patient with plasma cell leukemia in relapsing with impact of the central nervous system

M. Ortíz Espejo, N.H. Cahuana Santamaría, Paola Villanueva, Carmen Montes Gaisán et autres

es (code pays fourni par la source)

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

Laura Rosiñol Dachs, Carmen Montes Gaisán, Gabriela Bustamante, Sebastián Garzón López et autres

es (code pays fourni par la source)

How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma

Felipe de Arriba, Carmen Montes Gaisán, Javier de la Rubia

es (code pays fourni par la source)

Clinical and Demographic Characteristics of Multiple Myeloma Patients at Study Enrollment: Analysis of Doriant Study (NCT:04659798)

Carmen Montes Gaisán, Buenaventura Buendía, Fernando Escalante, Esther González García et autres

es (code pays fourni par la source)

Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM)

Camila Guerrero, Noemí Puig, María Teresa Cedena Romero, Ibai Goicoechea et autres

es (code pays fourni par la source)

MO371: Should We Systematically Look for Urine Alterations in all Patients With Monoclonal Gammopathy of Undetermined Significance?

M. Iturralde Ros, A. Maiztegi Azpitarte, M. Ortíz Espejo, Carmen Montes Gaisán et autres

es (code pays fourni par la source)

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

Artur Jurczyszyn, Jorge J. Castillo, Magdalena Olszewska‐Szopa, Lalit Kumar et autres

pl, us, in, cn, es, br, it (code pays fourni par la source)